Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AVTX US Equity

Avalo Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1534120 · FY ends Dec 31
$20.75
+1.04 (+5.28%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 13 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Nantahala Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Caligan Partners LPsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Avoro Capital Advisors LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Deep Track Capital, LPsec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Affinity Asset Advisors, LLCsec.gov ↗
2026-08-0713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-08-0713GSchedule 13G filed — ≥5% beneficial owner (passive) · by STATE STREET CORPsec.gov ↗
2026-08-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MILLENNIUM MANAGEMENT LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.